235 related articles for article (PubMed ID: 11161432)
1. MIP-1alpha is produced but it does not control pulmonary inflammation in response to respiratory syncytial virus infection in mice.
Domachowske JB; Bonville CA; Gao JL; Murphy PM; Easton AJ; Rosenberg HF
Cell Immunol; 2000 Nov; 206(1):1-6. PubMed ID: 11161432
[TBL] [Abstract][Full Text] [Related]
2. Ultrafine carbon black particles enhance respiratory syncytial virus-induced airway reactivity, pulmonary inflammation, and chemokine expression.
Lambert AL; Mangum JB; DeLorme MP; Everitt JI
Toxicol Sci; 2003 Apr; 72(2):339-46. PubMed ID: 12655033
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary eosinophilia and production of MIP-1alpha are prominent responses to infection with pneumonia virus of mice.
Domachowske JB; Bonville CA; Dyer KD; Easton AJ; Rosenberg HF
Cell Immunol; 2000 Mar; 200(2):98-104. PubMed ID: 10753501
[TBL] [Abstract][Full Text] [Related]
4. Epithelial cells infected with respiratory syncytial virus are resistant to the anti-inflammatory effects of hydrocortisone.
Bonville CA; Mehta PA; Krilov LR; Rosenberg HF; Domachowske JB
Cell Immunol; 2001 Nov; 213(2):134-40. PubMed ID: 11831875
[TBL] [Abstract][Full Text] [Related]
5. Chemokine expression during the development and resolution of a pulmonary leukocyte response to influenza A virus infection in mice.
Wareing MD; Lyon AB; Lu B; Gerard C; Sarawar SR
J Leukoc Biol; 2004 Oct; 76(4):886-95. PubMed ID: 15240757
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of respiratory syncytial virus infection with the CC chemokine RANTES (CCL5).
Elliott MB; Tebbey PW; Pryharski KS; Scheuer CA; Laughlin TS; Hancock GE
J Med Virol; 2004 Jun; 73(2):300-8. PubMed ID: 15122808
[TBL] [Abstract][Full Text] [Related]
7. Respiratory syncytial virus infection in a murine model of cystic fibrosis.
Colasurdo GN; Fullmer JJ; Elidemir O; Atkins C; Khan AM; Stark JM
J Med Virol; 2006 May; 78(5):651-8. PubMed ID: 16555274
[TBL] [Abstract][Full Text] [Related]
8. Primary infection of mice with high titer inoculum respiratory syncytial virus: characterization and response to antiviral therapy.
Bolger G; Lapeyre N; Dansereau N; Lagacé L; Berry G; Klosowski K; Mewhort T; Liuzzi M
Can J Physiol Pharmacol; 2005 Feb; 83(2):198-213. PubMed ID: 15791294
[TBL] [Abstract][Full Text] [Related]
9. Functional antagonism of chemokine receptor CCR1 reduces mortality in acute pneumovirus infection in vivo.
Bonville CA; Lau VK; DeLeon JM; Gao JL; Easton AJ; Rosenberg HF; Domachowske JB
J Virol; 2004 Aug; 78(15):7984-9. PubMed ID: 15254170
[TBL] [Abstract][Full Text] [Related]
10. Respiratory syncytial virus induces pneumonia, cytokine response, airway obstruction, and chronic inflammatory infiltrates associated with long-term airway hyperresponsiveness in mice.
Jafri HS; Chavez-Bueno S; Mejias A; Gomez AM; Rios AM; Nassi SS; Yusuf M; Kapur P; Hardy RD; Hatfield J; Rogers BB; Krisher K; Ramilo O
J Infect Dis; 2004 May; 189(10):1856-65. PubMed ID: 15122522
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in the respiratory tracts of human infants following paramyxovirus infection.
Elliott MB; Welliver RC; Laughlin TS; Pryharski KS; LaPierre NA; Chen T; Souza V; Terio NB; Hancock GE
J Med Virol; 2007 Apr; 79(4):447-56. PubMed ID: 17311330
[TBL] [Abstract][Full Text] [Related]
12. Glucocorticoid administration accelerates mortality of pneumovirus-infected mice.
Domachowske JB; Bonville CA; Ali-Ahmad D; Dyer KD; Easton AJ; Rosenberg HF
J Infect Dis; 2001 Dec; 184(12):1518-23. PubMed ID: 11740726
[TBL] [Abstract][Full Text] [Related]
13. The pneumonia virus of mice infection model for severe respiratory syncytial virus infection: identifying novel targets for therapeutic intervention.
Rosenberg HF; Bonville CA; Easton AJ; Domachowske JB
Pharmacol Ther; 2005 Jan; 105(1):1-6. PubMed ID: 15626452
[TBL] [Abstract][Full Text] [Related]
14. The chemokine macrophage-inflammatory protein-1 alpha and its receptor CCR1 control pulmonary inflammation and antiviral host defense in paramyxovirus infection.
Domachowske JB; Bonville CA; Gao JL; Murphy PM; Easton AJ; Rosenberg HF
J Immunol; 2000 Sep; 165(5):2677-82. PubMed ID: 10946298
[TBL] [Abstract][Full Text] [Related]
15. Inducible expression of inflammatory chemokines in respiratory syncytial virus-infected mice: role of MIP-1alpha in lung pathology.
Haeberle HA; Kuziel WA; Dieterich HJ; Casola A; Gatalica Z; Garofalo RP
J Virol; 2001 Jan; 75(2):878-90. PubMed ID: 11134301
[TBL] [Abstract][Full Text] [Related]
16. TNF and IL-6 mediate MIP-1alpha expression in bleomycin-induced lung injury.
Smith RE; Strieter RM; Phan SH; Lukacs N; Kunkel SL
J Leukoc Biol; 1998 Oct; 64(4):528-36. PubMed ID: 9766634
[TBL] [Abstract][Full Text] [Related]
17. Respiratory syncytial virus-induced CCL5/RANTES contributes to exacerbation of allergic airway inflammation.
John AE; Berlin AA; Lukacs NW
Eur J Immunol; 2003 Jun; 33(6):1677-85. PubMed ID: 12778486
[TBL] [Abstract][Full Text] [Related]
18. Regulation of macrophage inflammatory protein-1 alpha expression and function by endogenous interleukin-10 in a model of acute inflammation.
Ajuebor MN; Das AM; Virág L; Szabó C; Perretti M
Biochem Biophys Res Commun; 1999 Feb; 255(2):279-82. PubMed ID: 10049699
[TBL] [Abstract][Full Text] [Related]
19. Host transcription profiles upon primary respiratory syncytial virus infection.
Janssen R; Pennings J; Hodemaekers H; Buisman A; van Oosten M; de Rond L; Oztürk K; Dormans J; Kimman T; Hoebee B
J Virol; 2007 Jun; 81(11):5958-67. PubMed ID: 17376894
[TBL] [Abstract][Full Text] [Related]
20. Respiratory syncytial virus-induced exaggeration of allergic airway disease is dependent upon CCR1-associated immune responses.
John AE; Gerard CJ; Schaller M; Miller AL; Berlin AA; Humbles AA; Lukacs NW
Eur J Immunol; 2005 Jan; 35(1):108-16. PubMed ID: 15593301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
